Li Jun Yao
Fondatore presso KONFOONG MATERIALS INTERNATIONAL CO., LTD
Patrimonio netto: 365 M $ in data 31/05/2024
Profilo
Li Jun Yao is the founder of Konfoong Materials International Co., Ltd., which was founded in 2005.
He currently holds the position of Chairman & Chief Technology Officer at Konfoong Materials International Co., Ltd.
Additionally, Dr. Yao is the Vice Chairman at Konfoong Biotech International Co., Ltd.
and the Chairman at TCPR (Shanghai) Electro-Mechanical High-Tech Co., Ltd.
Dr. Yao has a doctorate degree from Hiroshima University and Harbin Institute of Technology.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
30/09/2023 | 42 764 051 ( 47.57% ) | 275 M $ | 31/05/2024 | |
30/09/2023 | 14 001 673 ( 8.43% ) | 90 M $ | 31/05/2024 |
Posizioni attive di Li Jun Yao
Società | Posizione | Inizio |
---|---|---|
KONFOONG MATERIALS INTERNATIONAL CO., LTD | Fondatore | 14/04/2005 |
TCPR (Shanghai) Electro-Mechanical High-Tech Co., Ltd.
TCPR (Shanghai) Electro-Mechanical High-Tech Co., Ltd. Metal FabricationProducer Manufacturing TCPR (Shanghai) Electro-Mechanical High-Tech Co., Ltd. engages in the research and development, and production of ultra-high purity tantalum materials and aluminum alloy materials, semiconductor machine cavity materials, and special stainless steel materials. It also offers special powder metallurgy materials, and medical high-purity titanium and alloy materials. The company was founded on December 5, 2012 and is headquartered in Shanghai, China. | Presidente | - |
Konfoong Biotech International Co., Ltd.
Konfoong Biotech International Co., Ltd. Medical SpecialtiesHealth Technology Konfoong Biotech International Co., Ltd. is a high-tech bio-information technology enterprise based in China. The Chinese company has built numerous pathology teleconsultation platforms, including several provincial centers nationwide, and its digital pathology products have been implemented in almost 1,000 hospitals across the country. Konfoong Biotech has also been actively incorporating artificial intelligence technology to promote product innovation and has launched over 10 artificial intelligence-aided pathology diagnosis projects, such as cervical fluid-based cytology, liver pathology, kidney pathology, and breast pathology, to develop intelligent pathology-aided diagnosis systems. The company was founded in 2011 by Bing Xian Liu, who has been the CEO since then. | Direttore/Membro del Consiglio | - |
Formazione di Li Jun Yao
Harbin Institute of Technology | Doctorate Degree |
Hiroshima University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
KONFOONG MATERIALS INTERNATIONAL CO., LTD | Electronic Technology |
Aziende private | 2 |
---|---|
TCPR (Shanghai) Electro-Mechanical High-Tech Co., Ltd.
TCPR (Shanghai) Electro-Mechanical High-Tech Co., Ltd. Metal FabricationProducer Manufacturing TCPR (Shanghai) Electro-Mechanical High-Tech Co., Ltd. engages in the research and development, and production of ultra-high purity tantalum materials and aluminum alloy materials, semiconductor machine cavity materials, and special stainless steel materials. It also offers special powder metallurgy materials, and medical high-purity titanium and alloy materials. The company was founded on December 5, 2012 and is headquartered in Shanghai, China. | Producer Manufacturing |
Konfoong Biotech International Co., Ltd.
Konfoong Biotech International Co., Ltd. Medical SpecialtiesHealth Technology Konfoong Biotech International Co., Ltd. is a high-tech bio-information technology enterprise based in China. The Chinese company has built numerous pathology teleconsultation platforms, including several provincial centers nationwide, and its digital pathology products have been implemented in almost 1,000 hospitals across the country. Konfoong Biotech has also been actively incorporating artificial intelligence technology to promote product innovation and has launched over 10 artificial intelligence-aided pathology diagnosis projects, such as cervical fluid-based cytology, liver pathology, kidney pathology, and breast pathology, to develop intelligent pathology-aided diagnosis systems. The company was founded in 2011 by Bing Xian Liu, who has been the CEO since then. | Health Technology |
- Borsa valori
- Insiders
- Li Jun Yao